Advisory Committee on Breast Cancer in Young Women; Notice of Charter Renewal

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

June 28, 2022

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Abstract

This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Advisory Committee on Breast Cancer in Young Women (ACBCYW), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through June 17, 2024.

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 123 (Tuesday, June 28, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 123 (Tuesday, June 28, 2022)]
[Notices]
[Page 38407]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-13686]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Breast Cancer in Young Women; Notice of 
Charter Renewal

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of charter renewal.

-----------------------------------------------------------------------

SUMMARY: This gives notice under the Federal Advisory Committee Act of 
October 6, 1972, that the Advisory Committee on Breast Cancer in Young 
Women (ACBCYW), Centers for Disease Control and Prevention, Department 
of Health and Human Services, has been renewed for a 2-year period 
through June 17, 2024.

FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, MBA, MHA, 
Designated Federal Officer, National Center for Chronic Disease 
Prevention and Health Promotion, CDC, 4770 Buford Highway NE, Mailstop 
S107-4, Atlanta, Georgia 30341-3717; Telephone: (404) 498-0073; Email: 
<a href="/cdn-cgi/l/email-protection#602b25330d091408200304034e070f16"><span class="__cf_email__" data-cfemail="f3b8b6a09e9a879bb3909790dd949c85">[email&#160;protected]</span></a>.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-13686 Filed 6-27-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on June 28, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.